logo
The ‘N' in SNAP Means Nutrition

The ‘N' in SNAP Means Nutrition

Epoch Times16-05-2025

Commentary
SNAP, or Supplemental Nutrition Assistance Program, also known as food stamps, is one of the nation's largest welfare programs.
And, like all welfare programs, it is massive, it has grown prodigiously over the years and it is inefficient.
One glaring issue, which is gaining attention as a result of new Health and Human Services Secretary Robert F. Kennedy Jr.'s Make America Healthy Again campaign, is the kinds of foods that recipients of SNAP funds can purchase.
And here we have convergence of bodily health and fiscal health.
The 'N' in SNAP stands for nutrition. The point of the whole program is to help poor Americans eat and not forgo nutrition as result of insufficient funds to buy food. So why should government funds be used to purchase foods that are not fundamental to meeting the requirements of basic nutrition?
Related Stories
5/13/2025
5/5/2025
The program is funded by the federal government but administered by the states.
Now three Republican governors—governors of Arkansas, Idaho and Indiana—are joining the governor of West Virginia in seeking waivers from the federal government to permit them to remove soda, candy, and other sweets from the foods that can be purchased with SNAP funds.
SNAP funds flow from the Department of Agriculture, and new Agriculture Secretary Brooke Rollins showed her support for this move by appearing alongside of Arkansas Gov. Sarah Huckabee Sanders when she announced that her state would seek a waiver to eliminate soda and candy.
According to the Foundation for Government Accountability, 'Soda is the number one commodity purchased with food stamps. More food stamp money is spent on soda, candy, snacks, ice cream, and cakes than on fruit, vegetables, eggs, pasta, beans, and rice. Purchases of sweetened beverages, desserts, salty snacks, and candy exceed the program's combined sales of fruits and vegetables by $9.4 billion a year.'
FGA goes on to point out that the incidence of obesity is higher among food stamp recipients than among those not on food stamps at similar income levels and that food stamp participants are 'more likely to be at very high or extremely high risk' of the many health problems that result from obesity.
Per the Federal Reserve Bank of St. Louis, in 1975, federal funding to the SNAP program was $4.6 billion. By 2000, it was $14.6 billion. In 2023, it was up to $111.2 billion.
Per Pew Research, in 1974, there were 12.9 million Americans receiving SNAP funds. In 2023, it was up to 42.4 million.
Most recipients are adults—63 percent are over the age of 18—and of adults receiving food stamps, 62 percent had not been employed at all during the year, 24 percent were employed over the year and 14 percent were employed part of the year.
Among children receiving food stamp payments, 56 percent were in homes with one or no parent.
Much discussion about reform of SNAP involves a more rigorous application of work requirements to receive funding. This points back to importance of health. If SNAP funds permit purchase of foods that are unhealthy, or damage health, so it seems SNAP funds contribute to undermining the ability of recipients to work.
Needless to say, as this initiative gains momentum, as it should, and as more states seek waivers to streamline their SNAP funding to foods that clearly aim to fundamental nutritional needs, the beverage and candy industry can be expected to be all over Congress to block the change.
The Wall Street Journal reported last December about ramped up lobbying by Coke, Pepsi and the American Beverage Association to leave their soft drinks in the purview of SNAP funding.
Some concerns have been expressed by grocers that increased specificity regarding what can be purchased can make administration and monitoring difficult. But surely technology can deal with this.
Removing non-nutritious foods and beverages from SNAP won't balance our federal budget. But it is a no-brainer for our fiscal and physical health.
Views expressed in this article are opinions of the author and do not necessarily reflect the views of The Epoch Times.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Biden should've been given multiple cognitive tests while in the White House, Obama's doctor says
Biden should've been given multiple cognitive tests while in the White House, Obama's doctor says

New York Post

time2 hours ago

  • New York Post

Biden should've been given multiple cognitive tests while in the White House, Obama's doctor says

WASHINGTON — Joe Biden's doctor should've made him undergo multiple neurocognitive tests during his presidency, former President Barack Obama's physician told The Post. Jeffrey Kuhlman, who served as Obama's doctor from 2009 to 2013, highlighted in a phone interview Saturday how Biden — and all politicians over the age of 70 — should be submitted to 'a few hours' of annual mental exams and release those results to the public. 'My position is that a 78-year-old candidate, Trump at the time, an 82-year-old president [Biden] would both benefit from neurocognitive testing,' said Kuhlman, who published a book 'Transforming Presidential Healthcare,' recommending that in November 2024. Advertisement 'Any politician over the age of 70 has normal age-related cognitive decline,' Kuhlman said, pointing out that he's been making the recommendation for nearly a year — and did so in a New York Times op-ed on the day Biden bowed out of the 2024 race. 'If you look at his three physicals that were released as president, Dr. [Kevin] O'Connor wrote five to six pages, single-spaced. He referenced 10 to 20 specialist physicians.' 5 Joe Biden's doctor should've made him undergo multiple neurocognitive tests during his presidency, former President Barack Obama's physician told The Post. Getty Images Advertisement But the tests did not include any neurocognitive work, nor did Biden submit to the Montreal Cognitive Assessment, as Trump did in his first term, a two-minute screening comprising around 30 questions to test for signs of dementia, according to Obama's ex-physician. 'I have no doubt that President Trump aced it,' he said of the test, but said the current White House, in the interest of full transparency, should also release CT scans that were taken after the assassination attempt against the Republican candidate in Butler, Pa., last July. Kuhlman added the Montreal Cognitive Assessment isn't adequate to determine more serious mental slippage, one of the three main areas that medical professionals should be considering when evaluating the president, along with cancer and cardiovascular issues. Memory, reasoning, speed of processing and spacial visualization all begin to decline around the age of 60, he also said. Advertisement 5 Kevin O'Connor served as Biden's doctor during his vice presidency, overlapping with Kuhlman in the White House medical unit. David Lienemann/The White House O'Connor served as Biden's doctor during his vice presidency, overlapping with Kuhlman in the White House medical unit. Kuhlman said he 'respects' O'Connor's 'medical judgment,' but also told The Washington Post: 'Sometimes those closest to the tree miss the forest.' In apparently his only media interview during Biden's term, O'Connor insisted to The Post in July 2024 that the president's cognitive health was 'excellent' — days after being forced out of a re-election bid and replaced by Vice President Kamala Harris due to a dismal debate performance June 27. Advertisement 5 Kuhlman said he 'respects' O'Connor's 'medical judgment,' but also told The Washington Post: 'Sometimes those closest to the tree miss the forest.' Getty Images In a break from his predecessors, Biden's doctor never answered questions from the press in the White House briefing room but submitted annual physical reports that noted some physical ailments without addressing the president's mental acuity, other than to say he was 'fit for duty.' 'The president doesn't need a cognitive test,' claimed White House press secretary Karine Jean-Pierre in a February 2024 briefing following what would be Biden's final physical as commander-in-chief. 'He passes a cognitive test every day.' White House visitor logs show the oldest-ever president did submit to evaluation from an expert in Parkinson's disease and 20-year veteran of Walter Reed National Military Medical Center, Dr. Kevin Cannard, but O'Connor said the January 2024 meeting was part of Biden's annual physical. 'If somebody turns up a report that Kevin Cannard said he has Parkinson's,' said Kuhlman, 'then that's a completely different story, but we have 14 years of Kevin Cannard evaluating him and that's who I would trust.' 5 O'Connor said that was part of his annual physical and ruled out a Parkinson's diagnosis, though other doctors expressed skepticism. American Osteopathic Association O'Connor said that was part of his annual physical and ruled out a Parkinson's diagnosis, though other doctors expressed skepticism. 'I could've diagnosed him from across the Mall,' neurologist Dr. Tom Pitts told NBC in July 2024, pointing to Biden's 'rigidity,' 'shuffling gait' and 'slow movement.' Advertisement Special Counsel Robert Hur, who determined that Biden 'willfully' hoarded classified documents after leaving the Obama White House, chose not to bring charges months earlier that year in February, in part because a jury would view the president as a 'sympathetic, well-meaning elderly man with a poor memory.' The Republican-led House Oversight Committee subpoenaed O'Connor on Thursday to appear for questioning about the former president's mental abilities on June 27. 5 The Republican-led House Oversight Committee subpoenaed O'Connor on Thursday to appear for questioning about the former president's mental abilities on June 27. AP Oversight Chairman James Comer (R-Ky.) in a cover letter accompanying the subpoena suggested the doctor's past 'financial relationship with the Biden family' may have 'contributed to an effort to hide former President Biden's fitness to serve from the American people.' Advertisement Jean-Pierre, who left the Democratic Party and is publishing a tell-all book about the 'broken' Biden administration, is also expected to be hauled in for testimony. Days before a book was set to be published alleging a vast cover-up of his decline during his last two years in the White House, Biden announced that he had been diagnosed with prostate cancer that had spread to his bones. The book, 'Original Sin,' notes that O'Connor was reluctant to administer a cognitive test, according to co-authors Jake Tapper and Alex Thompson. Advertisement Kuhlman said O'Connor had conducted tests for that kind of cancer between 2009 and 2014 when they served together in the White House, but it may not have been 'worth doing in the next 10 years' based on the findings of that final exam, known as a PSA, in the vice presidency. 'I hope that Kevin O'Connor had that conversation every year with his patient, Joe Biden, and documented that in the medical record,' he said. 'If he did the PSA and chose not to release it, I don't agree with that.'

Psychedelics as potential mental health treatment are explored by Trump administration
Psychedelics as potential mental health treatment are explored by Trump administration

Yahoo

time3 hours ago

  • Yahoo

Psychedelics as potential mental health treatment are explored by Trump administration

The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration

New bill would mandate 'anti-choking' devices in NYC schools
New bill would mandate 'anti-choking' devices in NYC schools

New York Post

time3 hours ago

  • New York Post

New bill would mandate 'anti-choking' devices in NYC schools

Every school in NYC would be required to have 'airway clearance devices' to help prevent choking deaths under a City Council bill gaining bipartisan steam. The legislation sponsored by Bronx Republican Kristy Marmorato would mandate that city schools stock the portable, suction-based devices on site. It already has support from 11 Democrats and four other Republicans, and was expected to be the subject of a public hearing this month. The devices, which can be self-administered and are considered an alternative to the Heimlich maneuver, usually run $50 to $70 each, but Long Island-based LifeVac has offered to supply each Big Apple school with a device and an instructional video on how they work at no charge, according to the company. 3 NYC Councilwoman Kristy Marmorato (R-Bronx) sponsored a bill that would mandate city schools stock 'airway clearance devices' to help prevent choking deaths. James Keivom Heidi Felix, LifeVac's vice president of sales, said the company has already donated more than 10,000 devices to schools nationwide and welcomes doing the same in NYC. There's more than 1,800 public schools and about 900 private schools in the Big Apple. The issue is personal for Marmorato. 3 LifeVac has already donated more than 10,000 devices to schools nationwide and welcomes doing the same in NYC. LifeVac She had a scary incident eight years ago when her then-18-month-old daughter choked on a piece of apple. A trained health care professional, Marmorato was able to save her daughter — but recalled it was a 'very frightening experience.' Her grandfather, Michael Rendino, died three decades ago while choking on a piece of meat at a restaurant after the Heimlich maneuver failed. 3 More than 1,800 public schools and about 900 private schools in the Big Apple would have the life-saving devices under the bill. Monkey Business – 'This is not just about my child,' she said. 'It's about all the children in New York City. Even if one device saves one kid's life, it's tremendous, and it's a win for parents and families.' She said she expects the legislation to be approved,considering it won't cost taxpayers a cent. Albany pols are reviewing similar legislation to require schools statewide to stock 'airway clearance devices.' City Hall spokesman Zachary Nosanchuk said the Department of Education and Mayor's Office will review the legislation, but added 'we continue to train [school] staff to use the Heimlich maneuver' because it remains the 'recommended first-aid technique to save children who are choking.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store